Interstitial lung changes and persistent COVID ‐19 in a patient with follicular lymphoma: A case report

Herein, we report a case of COVID-19 persisting longer than 11  months which developed interstitial changes in the lungs that were recalcitrant to corticosteroid therapy. AbstractWe herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID-19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID-19, which can be life-threatening for immunocompromised patients. Thus, further investigation is warranted.
Source: Respirology Case Reports - Category: Respiratory Medicine Authors: Tags: CASE REPORT Source Type: research